Skip to main content

Table 5 Pharmacological groups not recommended in the elderly that generated PREFASEG alerts from January 2016–December 2018

From: Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia

Not recommended pharmacological groups Alerts generated Total accepted % Accepted
Benzodiazepines, hypnotics, and sedatives 172,574 47,966 27
Anti-inflammatory and anti-rheumatic (NSAIDs, COXIBS) 94,034 20,627 22
Antihypertensives 34,542 10,310 30
Digestive system (otilonium, metoclopramide, glibenclamide, chlorporpamide) 31,496 8945 28
Chronic obstructive pulmonary disease treatments (theophylline) 19,285 4758 25
Central action muscle relaxants (cyclobenzaprine) 18,170 7521 41
Tricyclic antidepressants and Fluoxetine 17,289 5654 33
Peripheral vasodilators (pentoxifilline, nicergoline, nafthydrofuril) 16,958 6621 39
Respiratory system (systemic antihistamines) 14,219 4917 35
Hormone therapy (megestrol) 10,776 2631 24
Urinary antispasmodics (oxybutynin) 7018 2495 36
Antithrombotics (cilostazol) 3270 1100 34
Beta-blockers (sotalol) 1105 392 35
Opioid and anti-migraine pain relievers 868 342 39
Antiparkinsonian drugs 316 105 33